Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

I'm going to describe three examples of novel therapeutic approaches for the prevention and treatment of diabetic complications, all based on the new paradigm of a unifying mechanism for the ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Regular physical activity is crucial for slowing biological aging in type 2 diabetes, with specific thresholds identified for ...

Researchers from Nanjing University and the Army Engineering University of PLA have published a review in ExRNA, shedding ...

an investigational therapy for obesity and diabetes. MD-18 is a new peptide targeting protein-tyrosine phosphatase 1B (PTP1B) ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Researchers have been able to demonstrate that type 2 diabetic patients, when placed on a carbohydrate-restricted diet, are ...